Recurrent prostate adenocarcinoma
Clinical trials for Recurrent prostate adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent prostate adenocarcinoma trials appear
Sign up with your email to follow new studies for Recurrent prostate adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
Disease control Recruiting nowThis phase II trial tests whether adding a targeted radiation drug (177Lu-PSMA-617) to standard hormone therapy, with or without additional hormone-blocking pills, can better control low-volume metastatic hormone-sensitive prostate cancer. The study enrolls men whose cancer has s…
Matched conditions: RECURRENT PROSTATE ADENOCARCINOMA
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive One-Two punch takes on returning prostate cancer
Disease control Recruiting nowThis phase II trial is testing two radioactive drugs, 225Ac-PSMA-617 and 177Lu-PSMA-617, combined with precise radiation therapy for prostate cancer that has returned and spread to a few spots in the body. The drugs target a protein on cancer cells and deliver radiation to kill t…
Matched conditions: RECURRENT PROSTATE ADENOCARCINOMA
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC